Liver Elastography clinical trials

Explore recruiting liver elastography clinical trials.

Recruiting liver elastography studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Liver Elastography trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Reducing Non-Alcoholic Steatohepatitis

Czechia

Therapeutic use (Phase IV) EU CTIS Study details

A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 2b/3 Study to Evaluate the Efficacy and Safety of Saroglitazar Magnesium in Subjects with Primary Biliary Cholangitis

Iceland

Phase II and Phase III (Integrated) EU CTIS Study details

A Phase 2b Randomized, Open-Label Study to Evaluate the Efficacy and Safety of Tobevibart+Elebsiran Combination Therapy versus Bulevirtide in Participants with Chronic HDV Infection (ECLIPSE 3)

Bulgaria, Italy, Netherlands, Germany, Belgium, Spain +2 more

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase 3 Randomized, Open Label Study to Evaluate the Efficacy and Safety of Tobevibart+Elebsiran Combination Therapy in Participants with Chronic HDV Infection Not Virologically Suppressed with Bulevirtide (ECLIPSE 2)

Romania, Austria, France, Spain, Italy, Germany

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase 3 Randomized, Open-Label Study to Evaluate the Efficacy and Safety of Tobevibart+Elebsiran Combination Therapy in Participants with Chronic HDV Infection (ECLIPSE 1)

Romania, France, Germany

Therapeutic confirmatory (Phase III) EU CTIS Study details

Efficacy of simvastatin reducing liver fibrosis in patients with advanced fibrosis due to alcohol: a randomized, double-blind, placebo-controlled clinical trial.

Spain

Phase II and Phase III (Integrated) EU CTIS Study details

Liver Elastography trials by city

Liver Elastography in Toronto Liver Elastography in Vancouver Liver Elastography in Montreal Liver Elastography in Calgary Liver Elastography in Edmonton Liver Elastography in Ottawa Liver Elastography in Winnipeg Liver Elastography in Quebec City Liver Elastography in Hamilton Liver Elastography in Kitchener Liver Elastography in London Liver Elastography in Halifax Liver Elastography in New York Liver Elastography in Los Angeles Liver Elastography in Chicago Liver Elastography in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease